TVARDI THERAPEUTICS, INC. (TVRD) Operating cash flow 2016–2025
TVARDI THERAPEUTICS, INC. (TVRD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$23.5MFY2025 · since FY2016: -$47.4M → -$23.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$23.5M | -28.4% |
| FY2024 | -$18.3M | +80.1% |
| FY2023 | -$92.1M | -17.0% |
| FY2022 | -$78.7M | -31.0% |
| FY2021 | -$60.1M | -995.1% |
| FY2020 | -$5.5M | +95.0% |
| FY2019 | -$109.2M | -389.8% |
| FY2018 | -$22.3M | +59.3% |
| FY2017 | -$54.8M | -15.7% |
| FY2016 | -$47.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TVRD financial trends
TVRD RevenueTVRD Net incomeTVRD Net marginTVRD Gross profitTVRD Gross marginTVRD Operating incomeTVRD Operating marginTVRD Free cash flowTVRD Capital expendituresTVRD Return on equityTVRD Stock buybacksTVRD Dividends paidTVRD Total assetsTVRD Total liabilitiesTVRD Shareholders’ equityTVRD overview →